首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 140 毫秒
1.
探讨单纯隆朋麻醉和隆朋麻醉下手术对犬内皮素(ET)和降钙素基因相关肽(CGRP)分泌的影响。方法:选取健康犬12只,将其随机均分为单纯隆朋麻醉组和隆朋麻醉手术组。两组均于麻醉前、0.5 h、2 h、8 h、24 h、48 h、72 h和120 h采集静脉血,并迅速离心取血浆,用放射性免疫法检测ET和CGRP的浓度。结果:麻醉组,ET出现上升趋势而CGRP呈现下降趋势。ET到2 h时恢复至麻前水平,CGRP到8 h时恢复至麻前水平。手术组,手术开始后ET和CGRP都呈现上升趋势,两者都在24 h时恢复至正常水平。结论:隆朋单纯麻醉时对ET和CGRP有轻微的影响,但隆朋麻醉手术时ET和CGRP都出现上升趋势,机体的应激反应较强烈。  相似文献   

2.
隆朋麻醉对犬红细胞免疫黏附性及红细胞膜流动性的影响   总被引:1,自引:0,他引:1  
本试验旨在研究隆朋麻醉对犬红细胞黏附性和膜流动性的影响。试验选用健康本地犬12只,肌肉注射隆朋3.0 mg/kg,于麻醉前(即0 h对照组)、麻醉后2、8、24、72、120、168 h动态采集5 mL外周静脉血,离心分离红细胞,制取红细胞悬液并制备试验用红细胞膜,进行C3b受体花环率和免疫复合物花环率的检测及红细胞膜流动性的检测。C3b受体花环率在麻醉后2 h出现下降趋势,但与对照组相比差异不显著(P>0.05),注射隆朋后8 h低于对照组且差异极显著(P<0.01),此后开始恢复,到麻醉后168 h基本恢复正常,与对照值相比差异不显著(P>0.05)。而免疫复合物花环率则呈现相反的趋势,其在注射隆朋后出现先上升后下降的趋势。免疫复合物花环率在注药后2~24 h高于对照组且差异极显著(P<0.01),72 h基本恢复,与对照组相比差异不显著(P>0.05)。使用荧光偏振法测定红细胞膜的流动性,结果表明,注射隆朋后犬红细胞膜流动性增加,但与对照组相比差异不显著(P>0.05)。隆朋麻醉对犬红细胞免疫黏附性及膜流动性皆存在影响,但对其膜流动性的影响不显著(P>0.05)。  相似文献   

3.
研究隆朋麻醉对犬4种促炎因子(IL-1β、IL-2、IL-8及TNF-α)的影响。12只健康犬分别于麻醉前(0 h)、麻醉后0.5、2、8、24、48、72 h及120 h共8个时间点,空腹采5 mL血离心取血清,动态检测IL-1β、IL-2、IL-8及TNF-α水平。结果为:IL-1β组只有麻醉后2 h的血清中IL-1β浓度显著低于0 h对照值(P0.05),其他各组的IL-1β浓度虽低于与0 h对照值,但比较差异不显著(P0.05)。IL-2在麻醉后出现下降趋势,在麻醉后48 h显著低于0 h对照值(P0.05),之后开始上升并于120 h基本恢复正常。IL-8组各时间点与0 h对照值比较皆差异不显著(P0.05)。TNF-α在麻醉后出现下降趋势,其中24、48 h与0 h对照值比较差异显著(P0.05),48 h后出现上升趋势,72 h与0 h对照值比较已差异不显著(P0.05),120 h基本回复正常。隆朋单一麻醉对犬4种细胞因子存在一定影响,各细胞因子在120 h后基本恢复正常。  相似文献   

4.
将12只健康本地犬,肌肉注射隆朋3.0 mg/kg,在注药前(即对照组)及注药后2、8、24、72、120、168 h静脉采血,分别测定红细胞三磷酸腺苷酶(ATPase)、总抗氧化能力(T-AOC)、超氧化物歧化酶(SOD)活性及丙二醛(MDA)含量.结果显示,注射隆朋后红细胞膜Na+-K+-ATPase、Ca2+-ATPase、Mg2+-ATPase三种酶活性均呈下降趋势,并在8 h均降到最低值,与对照值比较差异显著(P<0.05).注射隆朋后2 h T-AOC、SOD活性显著低于对照组(P<0.05);而MDA的含量在注药后2 h高于对照组且差异极显著(P<0.01),120 h基本恢复正常.本试验结果表明,隆朋对于犬红细胞膜Na+-K+-ATPase、Ca2+-ATPase、Mg2+-ATPase活性均有不同程度的抑制作用.隆朋对于犬的T-AOC及sOD的活性存在显著影响,并会引起红细胞分泌MDA含量升高,从而导致红细胞膜发生损伤.  相似文献   

5.
将20条杂种家犬随机分为4组进行临床麻醉实验,即静松灵组(A)、氯胺酮组(B)、静松灵与氯胺酮复合麻醉组(C)和846合剂组(D),分别检测犬在麻醉前、麻醉后30 m in、4 h、24 h、48 h 5个时点血清中天门冬酸氨基转移酶、丙氨酸氨基转移酶、尿素氮、肌酐的含量并进行分析比较。结论:C组、D组进行复合麻醉时比A组、B组单纯麻醉时对犬肝、肾功能影响小,说明对犬进行复合麻醉比单纯麻醉更为安全。  相似文献   

6.
试验选择隆朋、静松灵、氟哌利多、强痛宁进行犬的静脉复合麻醉,通过Datex循环监护仪对呼吸系统进行监测。结果表明:犬潮气量、每分通气量、呼气末CO2分压和注药前相比都有不同程度的升高,在麻醉后15~120min内显示平稳,无较大波动。说明隆朋复合麻醉剂对犬麻醉确实,麻醉诱导迅速,安全范围大,适合于犬的麻醉。  相似文献   

7.
研究临床上动物手术前应用盐酸赛拉嗪麻醉时对犬血清中3大营养代谢物质含量的影响。挑选8只健康犬,试验前犬禁食24 h、禁水12 h,分别在股四头肌肌肉注射0.24 mg/kg体重的塞拉嗪。分别在注射麻醉药后0、0.5、1、1.5、2 h颈静脉采血2 m L,常规分离血清,检测葡萄糖、甘油三脂、总胆固醇、总蛋白和白蛋白的含量。结果与试验开始相比,0.5 h、1.5 h、2 h血清葡萄糖含量极显著增加(P<0.01),而各时间点之间无显著差异(P>0.05);甘油三酯含量在试验开始后1.5 h和2 h时极显著下降(P<0.01)。整个试验期间血清总胆固醇、总蛋白和白蛋白含量均无显著变化(P>0.05)。结论是临床应用赛拉嗪用于犬麻醉时应密切关注由于塞拉嗪引起的血糖和甘油三酯含量变化对动物机体的影响,减少麻醉意外的发生。  相似文献   

8.
研究隆朋对大鼠不同脑区抑制性单胺类神经递质含量的变化影响,探讨隆朋麻醉作用机制。本试验将32只大鼠随机分为四组,分别为对照组,麻醉组,恢复Ⅰ组和恢复Ⅱ组,使用高效液相色谱法检测不同麻醉时期不同脑组织的5-羟色胺(5-HT)和5-羟吲哚乙酸(5-HIAA)的含量。结果隆朋作用后,大鼠大脑皮层、海马和丘脑5-HT和5-HIAA含量分别升高,且差异极显著。表明这三个脑区是隆朋作用脑组织的靶位区,由此推断隆朋可以通过促进海马、丘脑和大脑皮层内神经突触释放5-HT和5-HIAA而产生麻醉作用。  相似文献   

9.
研究异氟醚麻醉条件下高气腹压对犬氧化应激指标的影响,为腹腔镜技术在兽医临床推广提供一定的理论依据。方法:将12只健康本地犬分为对照组和气腹组(15 mm Hg),在异氟醚麻醉下建立气腹,检测各时间点的犬血清中总抗氧化能力(T-AOC)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)、还原型谷脘甘肽酶(GSH)和丙二醛(MDA)的水平。结果:相比于对照组,术后2 h和6 h气腹组的MDA水平显著升高(P0.05),SOD、CAT、GSH和T-AOC的水平显著降低(P0.05),术后24 h后均恢复正常。结论:在异氟醚麻醉条件下,高气腹压对犬氧化应激水平虽有影响,但可通过机体自我调节能力恢复。  相似文献   

10.
本实验应用隆朋复合强痛宁和氟哌利多对犬进行麻醉,并系统全面地对动物生理机能和生化指标进行监测.通过各项监测结果,评价隆朋复合强痛宁和氟哌利多对犬的麻醉效果及其安全性能,为其在临床中的应用和推广提供理论依据.  相似文献   

11.
Twenty-three dogs with heart failure were evaluated in a 12-month study by measuring baseline plasma atrial natriuretic peptide (ANP) concentrations. Ten dogs were classified as having mild to moderate cardiac disease (group 1) and 13 dogs were classified as having severe cardiac disease (group 2). The mean plasma ANP concentration for the group 1 dogs was 64 +/- 45 pg/mL and for the group 2 dogs, 328 +/- 122 pg/mL. The median survival time (1,095 d) for group 1 dogs was significantly greater (P < 0.05) than for group 2 dogs (58 d). A significantly (P < 0.05) greater median survival was noted for dogs with plasma ANP < 95 pg/mL (1095 d) compared with those with ANP > 95 pg/mL (58 d). Plasma ANP concentrations are a potential noninvasive predictor of survival in dogs with heart failure.  相似文献   

12.
Painful interventions can be performed on horse in standing position by means of sedative analgesia, also called standing-position anaesthesia. Combinations of anaesthetics are quite often used, in that context, for the purpose of producing analgetic effects stronger and more reliable than those that would be obtainable from one anaesthetic alone. The following combinations were comparatively tested for their analgetic and sedative effects and their effects upon the organism: Chloralhydrate with Ursonarkon (oxazolidone), Chloralhydrate with Rompun (xylazine), Chloralhydrate with morphine hydrochloride, Chloralhydrate with morphine hydrochloride and Ursonarkon, local anaesthesia in conjunction with sedation by Ursonarkon. 50 experiments were conducted on an experimental group of 10 horses under standardised conditions together with complementary tests on 71 horses under field conditions. The experimental methodology used for assessment of analgetic effects was based on defined electrical and thermic stimuli to enable determination of reactive thresholds. An objective comparison was thus possible between the above variants. Local anaesthesia in combination with complementary sedation proved to meet all demands on standing-position anaesthesia, as it was found to eliminate pain and tactile reflexes. Defence movements have to be expected, whenever preparations are used that attack the central nervous system, since while sensations of pain are suppressed, tactile stimuli may be met with reflex responses via the spinal cord and its intrinsic function.  相似文献   

13.
The pharmacokinetics of propofol, 6.5 mg/kg, administered as a bolus dose intravenously (i.v.) were studied in six dogs (group 1). The effect of maintaining anaesthesia with halothane and nitrous oxide in oxygen on propofol pharmacokinetics was also investigated in six dogs undergoing routine anaesthesia (group 2). Induction of anaesthesia was rapid in all animals. Post-induction apnoea was a feature in three of the 12 dogs. The blood propofol concentration-time profile was best described by a bi-exponential decline in two dogs in group 1 and in 3 dogs in group 2, and by a tri-exponential decline in four dogs in group 1 and 3 dogs in group 2. The elimination half-life was long in both groups (90.9 min and 75.2 min, respectively), the volume of distribution at steady state large (4889 and 4863 ml/kg) and the clearance rapid (58.6 and 56.3 ml/kg.min). There were no significant differences between the groups, thus indicating that maintenance of anaesthesia with halothane and nitrous oxide had no effect on the pharmacokinetics of propofol in the dog.  相似文献   

14.
Plasma concentrations of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were measured in 6 dogs with experimental mitral regurgitation (MR) and 19 canine patients with asymptomatic and symptomatic congestive heart failure (CHF). In dogs with experimental MR, ANP and BNP concentrations were significantly correlated with pulmonary capillary wedge pressure (PCWP) (ANP; r=0.852, P=0.0004, BNP; r=0.832, P=0.0008). ANP level was shown to have a predominant effect on PCWP in comparison with BNP using multiple regression analysis. In canine patients with asymptomatic and symptomatic CHF, ANP and BNP concentrations were significantly different among the heart failure classes according to the New York Heart Association functional classification (ANP; P=0.0165, BNP; P=0.0005). In addition, ANP and BNP levels in dogs with decompensated heart failure (n=10) significantly increased in comparison with those in dogs with compensated heart failure (n=9). There was however no correlation between ANP and BNP levels in each heart failure class. In conclusion, plasma ANP and BNP levels may become predictors of PCWP and the severity of heart failure in dogs with MR, although further investigations on ANP and BNP levels in more clinical cases are required.  相似文献   

15.
The function of atrial natriuretic peptide (ANP) is claimed to be control of salt and water homeostasis, and thus, the hormone may be involved in the pathogenesis of certain diseases with impaired volume regulation. We, therefore, studied plasma ANP concentration in dogs with chronic renal failure, congestive heart failure, and hyperadrenocorticism. Dogs with chronic renal failure had twofold higher plasma ANP concentration (16.2 +/- 5.8 fmol/ml), compared with healthy dogs (8.3 +/- 3.5 fmol/ml). An even more distinct increase (sixfold) of plasma ANP concentration was found in dogs with congestive heart failure (52.9 +/- 29.7 fmol/ml). In contrast, dogs with hyperadrenocorticism did not have high ANP plasma concentration (5.5 +/- 2.0 fmol/ml). High-performance liquid chromatographic analysis of plasma from dogs with congestive heart failure indicated that, in addition to the normal circulating form of ANP (99-126), the unprocessed precursor ANP (1-126) is detectable in the circulation. These qualitative and quantitative alterations of plasma ANP concentration in dogs further suggest involvement of this peptide in the development and/or maintenance of diseases associated with impaired volume regulation.  相似文献   

16.
The effects of halothane, isoflurane and sevoflurane anaesthesia on hepatic function and hepatocellular damage were investigated in dogs, comparing the activity of hepatic enzymes and bilirubin concentration in serum. An experimental study was designed. Twenty-one clinically normal mongrel dogs were divided into three groups and accordingly anaesthetized with halothane (n = 7), isoflurane (n = 7) and sevoflurane (n = 7). The dogs were 1-4 years old, and weighed between 13.5 and 27 kg (18.4 +/- 3.9). Xylazine HCI (1-2 mg/kg) i.m. was used as pre-anaesthetic medication. Anaesthesia was induced with propofol 2 mg/kg i.v. The trachea was intubated and anaesthesia maintained with halothane, isoflurane or sevoflurane in oxygen at concentrations of 1.35, 2 and 3%, respectively. Intermittent positive pressure ventilation (tidal volume, 15 ml/kg; respiration rate, 12-14/min) was started immediately after intubation and the anaesthesia lasted for 60 min. Venous blood samples were collected before pre-medication, 24 and 48 h, and 7 and 14 days after anaesthesia. Serum level of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and gamma-glutamyltransferase (GGT), lactate dehydrogenase (LDH GGT) activities and bilirubin concentration were measured. Serum AST, ALT and GGT activities increased after anaesthesia in all groups. In the halothane group, serum AST and ALT activities significantly increased all the time after anaesthesia compared with baseline activities. But in the isoflurane group AST and ALT activities increased only between 2 and 7 days, and in the sevoflurane group 7 days after anaesthesia. GGT activity was increased in the halothane group between 2 and 7 days, and in the isoflurane and sevoflurane groups 7 days after anaesthesia. All dogs recovered from anaesthesia without complications and none developed clinical signs of hepatic damage within 14 days. The results suggest that the use of halothane anaesthesia induces an elevation of serum activities of liver enzymes more frequently than isoflurane or sevoflurane from 2 to 14 days after anaesthesia in dogs. The effects of isoflurane or sevoflurane anaesthesia on the liver in dogs is safer than halothane anaesthesia in dogs.  相似文献   

17.
The concentration and molecular form of the plasma atrial natriuretic peptide (ANP) in dogs with mitral regurgitation was investigated. Plasma ANP concentration in dogs with mitral regurgitation was significantly increased (29.4 +/- 1.88 pmol litre-1, n = 40) compared to that in the controls (14.5 +/- 0.62 pmol litre-1, n = 20, P less than 0.01). Molecular forms of plasma ANP were determined by the gel permeation chromatogram. A single peak corresponding to alpha-ANP was detected in the plasma from the controls. However, a peak corresponding to beta-ANP and, or, gamma-ANP was detected in the plasma of the dogs with mitral regurgitation in addition to alpha-ANP. These results suggest that the process of ANP synthesis was altered and excretion of ANP from the heart was enhanced in dogs with mitral regurgitation.  相似文献   

18.
The effects of propofol alone or propofol and ketamine for the induction of anaesthesia in dogs were compared. Thirty healthy dogs were premedicated with acepromazine and pethidine, then randomly allocated to either treatment. Anaesthesia was induced with propofol (4 mg/kg bodyweight intravenously) (group 1), or propofol and ketamine (2 mg/kg bodyweight of each intravenously) (group 2). Anaesthesia was maintained with halothane, delivered in a mixture of oxygen and nitrous oxide (1:2) via a non-rebreathing Bain circuit. Various cardiorespiratory parameters were monitored at two, five, 10, 15, 20, 25 and 30 minutes after induction, and the animals were observed during anaesthesia and recovery, and any adverse effects were recorded. During anaesthesia, the heart rate, but not the systolic arterial pressure, was consistently higher in group 2 (range 95 to 102 beats per minute) than in group 1 (range 73 to 90 beats per minute). Post-induction apnoea was more common in group 2 (11 of 15) than in group 1 (six of 15). Muscle twitching was observed in three dogs in each group. Recovery times were similar in both groups. Propofol followed by ketamine was comparable with propofol alone for the induction of anaesthesia in healthy dogs.  相似文献   

19.
OBJECTIVE: To evaluate the use of measuring plasma concentrations of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and cardiac troponin-I (cTnI) to detect dogs with occult dilated cardiomyopathy (DCM). ANIMALS: 118 client-owned dogs. PROCEDURES: Dogs were prospectively examined by use of ECG; echocardiography; and evaluation of concentrations of ANP, BNP, and cTnI. Occult DCM was diagnosed by evaluation of echocardiographic left ventricular dimensions and detection of ventricular arrhythmias on ECG. Sensitivity and specificity of assays for measurement of plasma concentrations of ANP, BNP, and cTnI to detect dogs with occult DCM were determined. RESULTS: Occult DCM was diagnosed in 21 dogs. A concentration of > 6.21 pg/mL for BNP had a sensitivity of 95.2% and specificity of 61.9% for identifying dogs with occult DCM. In contrast, concentrations of ANP and cTnI had relatively low predictive values. CONCLUSIONS AND CLINICAL RELEVANCE: Blood-based screening for occult DCM in dogs can be accomplished by use of a BNP assay. Additional studies should be performed to optimize this method of screening dogs to detect occult DCM.  相似文献   

20.
Association between exogenous atrial natriuretic peptide (ANP) and hemodynamic changes was ascertained in 3 dogs with overt congestive heart failure (CHF(+)) and 3 dogs without congestive heart failure (CHF(-)) caused by experimental mitral regurgitation (MR). The hemodynamic measurements were recorded in all dogs during and after 1 hr infusion of ANP at the rate of 0.1 (low dose), 0.5 (medium dose) and 1.0 (high dose) microg/kg/min, respectively. Heart rate, mean arterial pressure, pulmonary capillary wedge pressure (PCWP) and systemic vascular resistance decreased significantly during and after ANP infusion even with low dose in the CHF(+). Stroke volume, stroke volume index and cardiac output in the CHF(+) during and after ANP infusion showed an increasing trend as compared with the CHF(-). Double product, an indicator of myocardial oxygen consumption, significantly decreased during and after ANP administration at all doses in the CHF(+). These findings indicate that even at low dose, exogenous ANP improves cardiac performance and reduces myocardial oxygen consumption in the CHF(+), and suggest that ANP has beneficial effects in the treatment of dogs with overt congestive heart failure resulting from MR.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号